Helen Susan Kim is VP at Kite Pharma, Inc. (KITE). They have made 20 open-market trades across 4 companies since 2008, most recently 2026-01-12.
CIK 0001422772
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $15.1M since 2008, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AKTS | 4,859,370 | $73.2M |
| KITE | 17,500 | $3.1M |
| AMTI | 575,250 | $151K |
| KOSN | 6,539 | — |
| Total | $76.5M |
Shares reported on the most recent Form 4, priced at the 2026-01-12 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AKTS | BUY | 2026-01-12 | 2026-01-12 | $18.00 | $15.0M | -6.1% | -21.6% | -24.6% |
| AMTI | SELL | 2021-08-26 | 2021-08-27 | $30.16 | $860K | -8.6% | -8.9% | -47.6% |
| AMTI | SELL | 2021-08-24 | 2021-08-25 | $30.08 | $585K | +0.4% | -7.4% | -37.9% |
| AMTI | SELL | 2021-07-02 | 2021-07-06 | $43.32 | $17.3M | -14.1% | -32.1% | -41.9% |
| KITE | SELL | 2017-09-25 | 2017-09-27 | $179.66 | $1.1M | N/A | N/A | N/A |
| KITE | SELL | 2017-08-10 | 2017-08-14 | $120.09 | $1.5M | +13.5% | +45.0% | N/A |
| KITE | SELL | 2017-08-08 | 2017-08-10 | $119.56 | $9.6M | +12.8% | +48.2% | N/A |
| KITE | SELL | 2017-08-08 | 2017-08-10 | $119.12 | $5.2M | +12.8% | +48.2% | N/A |
| KITE | SELL | 2017-07-31 | 2017-08-01 | $109.28 | $2.9M | +10.7% | +64.1% | N/A |
| KITE | SELL | 2017-07-31 | 2017-08-01 | $110.06 | $1.2M | +10.7% | +64.1% | N/A |
| KITE | SELL | 2017-06-01 | 2017-06-05 | $72.45 | $174K | +19.7% | +45.3% | +142.9% |
| KITE | SELL | 2017-05-01 | 2017-05-03 | $82.12 | $197K | -7.8% | -7.7% | +32.0% |
| KITE | SELL | 2017-04-03 | 2017-04-04 | $81.80 | $196K | +8.0% | +10.2% | +37.4% |
| KITE | SELL | 2017-02-28 | 2017-03-02 | $67.60 | $2.9M | +13.2% | +5.5% | -2.4% |
| KITE | SELL | 2017-02-28 | 2017-03-02 | $67.78 | $3.4M | +13.2% | +5.5% | -2.4% |
| KITE | SELL | 2016-12-20 | 2016-12-22 | $50.86 | $48K | +8.3% | +0.0% | +66.4% |
| KITE | SELL | 2016-08-15 | 2016-08-16 | $63.01 | $151K | -5.4% | -10.7% | -15.8% |
| KITE | SELL | 2016-08-12 | 2016-08-16 | $60.27 | $2.2M | -5.4% | -10.7% | -15.8% |
| KITE | SELL | 2016-08-12 | 2016-08-16 | $60.08 | $2.0M | -5.4% | -10.7% | -15.8% |
| KOSN | BUY | 2008-03-14 | 2008-03-17 | $1.66 | $27K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.